Latest Breaking News On - Cain foundation laboratories - Page 1 : comparemela.com

Capsida Biotherapeutics Presents New Preclinical Evidence Indicating Novel First-in-Class IV-Administered Gene Therapy Effectively Treats Genetic Epilepsy Due to STXBP1 Mutations

/PRNewswire/ Capsida Biotherapeutics ("Capsida") today announced new preclinical data supporting the potential of Capsida s gene therapy candidate, CAP-002,.

Mingshan xueCapsida biotherapeuticsWu chenSusan catalanoHuman genetics at baylor college of medicineDepartment of molecularCapsida program for genetic epilepsy dueBaltimore convention centerBaylor college of medicineDepartment of neuroscienceAmerican society of gene cell therapyCain foundation laboratoriesAssociate professorHuman geneticsBaylor collegeDan duncan neurological research institute

Researchers Discover Novel Light-Gated Potassium Channel in Neurons

Researchers report they have identified the first natural light-gated potassium channel-rhodopsins.

Rice universityUnited statesBaylor college of medicineGraciela gutierrezMingshan xueYueyang gouRoberta welchElena govorunovaXiaoyu luJohn spudichMcgovern medical schoolCain foundation laboratoriesUniversity of guelphBaylor collegeTexas health science centerHouston mcgovern medical school

Pioneering study discovers an underlying cause for infantile spasms and points to novel therapy

Pioneering study discovers an underlying cause for infantile spasms and points to novel therapy
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

United statesJames frostJanne andersonCarlos ballester rosadoJohn swannCarrie mohilaJohn leHuman developmentNational institute of healthDevelopmental disabilities centersCain foundation laboratoriesMary cain pediatric neurology research foundationEpilepsy infantile spasms initiativeBaylor college of medicineDan duncan neurological research instituteTexas children